Cardiovascular Business Drives Response Biomedical Q3 Revenues up 69 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Response Biomedical said today that revenues in the third quarter increased 69 percent year over year.

Revenues in the quarter reached C$2.7 million (US$2.7 million), up from C$1.6 million a year ago. The firm said that cardiovascular sales rose 86 percent to C$2.6 million from C$1.4 million a year ago, driven primarily by business in China and Europe.

Its infectious disease, Bio-defense, and Environmental business, however, declined to C$85,000 from C$124,000 a year ago, a 31 percent drop.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.